AbCellera Biologics Inc. ( ABCL) - Stock Earnings
ABCL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026 AfterMarket | -0.13 / — | — | 10.6 million / — | — |
ABCL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | -43.2 million USD | 8.3 million USD |
| 2026Q2 | -55.4 million USD | 4.1 million USD |
| 2026Q3 | -40.8 million USD | 10.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ABCL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -146.4 million USD | 38.0 million USD |
| 2024 | -162.9 million USD | 28.8 million USD |
| 2025 | -146.4 million USD | 75.1 million USD |
| 2026 Est. | — | — |
ABCL
Price: $11.55
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 1.3 million
Market Capitalization: 3.9 billion